SEC Form 4 · accession 0001209191-15-074339
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
L Patrick Gage
Director
Period of report
Oct 2, 2015
Accepted (ET)
Oct 6, 2015 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 2, 2015 | M | 20,000 | $2.03 | A | 25,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Qualified Stock Option (Right to Buy)F1 | $2.03 | Oct 2, 2015 | M | 20,000 | A | — | Dec 8, 2021 | Common Stock | 20,000 | 34,544 | D |
Explanation of responses
- F1Vests in equal quarterly installments over a three-year period measured from the date of grant of December 9, 2011.